AdhexPharma acquires tesa Labtec from tesa SE

AdhexPharma acquired 100% of the shares in tesa Labtec GmbH from tesa SE. tesa Labtec is a CDMO offering formulation, development, and contract manufacturing of transdermal and topical patches and films. Terms were not disclosed.

“With this acquisition, AdhexPharma joins forces with tesa Labtec, a well-known CDMO company offering formulation, development, and contract manufacturing services of transdermal and topical patches as well as buccal and sublingual films.”milbank.com

• 1 source
• milbank.comMilbank Advises AdhexPharma on Acquisition of tesa LabtecDr. Michael Bernhardt, Dr. Leopold Riedl, Dr. Matthias Schell, LL.M.Oct 5, 2022

Summarized from public sources; check the original articles before acting on it.